Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Harpoon Therapeutics Inc (HARP)

17.31   0.05 (0.29%) 06-04 16:00
Open: 17.27 Pre. Close: 17.26
High: 18.15 Low: 17
Volume: 113,384 Market Cap: 433M
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead TriTAC product candidate is HPN424 that is in Phase I clinical trial for the treatment of metastatic castration-resistant prostate cancer. It also develops HPN536 for the treatment of ovarian cancer and other MSLN-expressing tumors; HPN217 for the treatment of multiple myeloma; and HPN328 for the treatment of SCLC. The company has a collaboration agreement with AbbVie Biotechnology Ltd. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.167 - 18.255 18.255 - 18.331
Low: 16.798 - 16.896 16.896 - 16.98
Close: 17.163 - 17.315 17.315 - 17.446

Technical analysis

as of: 2020-06-04 4:32:05 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 23.32     One year: 29.22
Support: Support1: 11.80    Support2: 9.82
Resistance: Resistance1: 19.97    Resistance2: 25.02
Pivot: 18.88
Moving Average: MA(5): 18.58     MA(20): 17.65
MA(100): 14.35     MA(250): 14.36
MACD: MACD(12,26): 1.39     Signal(9): 1.75
Stochastic oscillator: %K(14,3): 40.05     %D(3): 46.73
RSI: RSI(14): 50.65
52-week: High: 25.02  Low: 10.27  Change(%): 55.9
Average Vol(K): 3-Month: 15309  10-Days: 47636

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HARP has closed above bottom band by 37.1%. Bollinger Bands are 198.2% wider than normal. The large width of the bands suggest high volatility as compared to HARP's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Fri, 22 May 2020
Harpoon Therapeutics to Present Interim Clinical Data for TriTAC® HPN424 at the ASCO20 Virtual Scientific Program - GlobeNewswire

Mon, 11 May 2020
Analysts Are Much More Bearish On Harpoon Therapeutics, Inc. (NASDAQ:HARP) Than They Used To Be - Yahoo Finance

Wed, 06 May 2020
Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire

Fri, 29 May 2020
Harpoon Therapeutics Inc. (HARP) Presents Interim Phase 1 Data from Ongoing Dose Escalation Trial for PSMA-targeting TriTAC HPN424 at ASCO -

Mon, 01 Jun 2020
Top attractive stock of the week – Harpoon Therapeutics Inc. (HARP) - News RTS

Tue, 26 May 2020
Is Harpoon Therapeutics Inc (HARP) Stock a Top Performer in the Healthcare Sector? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 25
Shares Float (M) 4
% Held by Insiders 13.22
% Held by Institutions 77.35
Shares Short (K) 245
Shares Short P. Month (K) 312

Stock Financials

EPS -2.250
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.340
Profit Margin
Operating Margin -713.89
Return on Assets (ttm) -21.7
Return on Equity (ttm) -50.3
Qtrly Rev. Growth 210.2
Gross Profit (p.s.) -1.432
Sales Per Share 0.320
EBITDA (p.s.) -2.243
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M) -27

Stock Valuations

PE Ratio -7.69
PEG Ratio
Price to Book value 5.18
Price to Sales 54.03
Price to Cash Flow -54.23

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.